Y-mAbs Therapeutics, Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
YMAB on Nasdaq
Industry
Pharmaceutical Preparations
Location
230 Park Avenue, Suite 3350, New York, NY

Insiders trading volume in the past year

Y-mAbs Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Johan Wedell-Wedellsborg Director, 10%+ Owner $54.8M Jun 11, 2024
James Healy Director $26.7M Jun 11, 2024
WG Biotech ApS Director $9.12M Dec 11, 2023
Bo Kruse Evp, Cfo, Secry & Treas. $2.55M -$723K -22.1% May 30, 2024
Thomas Gad CHIEF BUSINESS OFFICER, Director $1.49M -$2.57M -63.2% Jan 17, 2025
Torben Lund-Hansen Svp & Chief Technical Officer $1.25M -$769K -38.1% Aug 28, 2024
Vignesh Rajah Svp & Chief Medical Officer $631K -$28.3K -4.29% Mar 5, 2024
Michael J. Rossi PRESIDENT & CEO, Director $618K Jan 17, 2025
Susan Laura Smith Svp & Chief Commercial Officer $561K -$27.8K -4.72% Mar 5, 2024
Peter P. Pfreundschuh CFO and Treasurer $341K Jan 17, 2025
Joris Wilms Svp & Chief Operating Officer $228K -$73.5K -24.3% Jan 17, 2025
Mary Tagliaferri Director $97.9K Jun 11, 2024
John LaRocca SVP, General Counsel & Secry $94.2K Jan 17, 2025
Steen Lisby Svp & Chief Scientific Officer $71.2K Jan 18, 2024
Ashu Tyagi Director $69.9K Jun 11, 2024
David N. Gill Director $69.9K Jun 11, 2024
Laura Hamill Director $69.9K Jun 11, 2024
Gerard Ber Director $19.3K -$8.66K -31% Jun 10, 2024
Douglas J. Gentilcore SVP, Danyelza Bus. Unit Head Jan 17, 2025
Moller-San Pedro Claus Juan Director and CEO, Director Dec 14, 2021

Recent Insider Transactions by Companies or Individuals for Y-mAbs Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.